glp 1 dizzy The Risk of Vestibular Disorders with Semaglutide and Tirzepatide: Findings from a Large Real-World Cohort Balance Disorders Archives - Dizzy
Description
It enhances insulin secretion from pancreatic -cells, and decreases glucagon release from pancreatic -cells [16]
[See Dosage and Administration
Some patients have side effects with any additives and brand name formulations
Intensive blood- glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
